Auszug
Andere Karzinome des Thorax gehen vom Mediastinum aus, vor allem aus dem vorderen Kompartment, wo Thymome bzw. Thymuskarzinome von malignen Keimzelltumoren unterschieden werden. Eine weitere maligne Tumorentität ist das Pleuramesotheliom, das auf die mediastinale Pleura übergreifen kann. Diese Karzinome des Thorax sind die Domäne multimodaler Therapiekonzepte. Ein differentialdiagnostisch hilfreiches Kriterium ist die Entwicklung der Geschwülste in typischer Lokalisation. Während sich die Thymuskarzinome und die malignen Keimzelltumoren im vorderen Kompartment des Mediastinums entwickeln, ist das Pleuramesotheliom eine Erkrankung der Pleurablätter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Albers P, Ganz A, Hannig E, Miersch WD, Muller SC (2000) Salvage surgery of chemorefractory germ cell tumors with elevated tumor markers. J Urol 164: 381–384
Baldini EH, Recht A, Strauss GM, DeCamp JMM, Swanson SJ (1997) Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63: 334–338
Benamore RE, O’Doherty MJ, Entwisle JJ (2005) Use of imaging in the management of malignant pleural mesothelioma. Clin Radiol 60: 1237–1247
Fizazi K, Tjulandin S, Salvioni R, Germa-Lluch JR, Bouzy J, Ragan D, Bokemeyer C, Gerl A, Flechon A, De Bono JS, Stenning S, Horwich A, Pont J, Albers P, De Giorgi U, Bower M, Bulanov A, Pizzocaro G, Aparicio J, Nichols CR, Theodore C, Hartmann JT, Schmoll HJ, Kaye SB, Culine S, Droz JP, Mahe C (2001) Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy. Results from an international study group. J Clin Oncol 19: 2647–2657
Kesler KA, Wilson JL, Cosgrove JA, Brooks JA, Messiha A, Fineberg NS, Einhorn LH, Brown JW (2005) Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: Analysis of a single-institution experience. J Thorac Cardiovasc Surg 130: 408–415
Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV (2004) Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44: 369–379
Levine GD, Rosai J (1978) Thymic hyperplasia and neoplysia: a review of current concepts. Hum Pathol 9(5): 495–515
Lucchi M, Ambrogi MC, Duranti L, Basolo F, Fontanini G, Angeletti CA, Mussi A (2005) Advanced stage thymomas and thymic carcinomas: results of multimodality treatments. Ann Thorac Surg 79: 1840–1844
Masaoka A, Monden Y, Nakahara K (1981) Follow-up study of thymoma with special references to their clinical stages. Cancer 48: 2485–2492
Moore KH, McKenzie PR, Kennedy CW, McCaughan BC (2001) Thymoma: trends over time. Ann Thorac Surg 72: 203–207
Müller-Hermelink HK, Marx A, Kirchner Th (1997) Advances in the diagnosis and classification of thymic epithelial tumors. Rev Adv Histopathology 17: 49–72
Neragi-Miandoab S (2006) Multimodality approach in management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 29: 14–19
Pass HI, Vogelzang N, Hahn S, Carbone M (2004) Malignant pleural mesothelioma. Curr Probl Cancer 28: 93–174
Rusch VW, Venkatraman ES (1999) Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68: 1799–1804
Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM, Swanson SJ, Buenor, Lukanich JM, Baldini EH, Mentzer SJ (1999) Resection margins, extrapleural modal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients. J Thorac Cardiovasc Surg 117(1): 54–56
Van Schil PV (2005) Malignant pleural mesothelioma: staging systems. Lung Cancer 49: S45–S48
Venuta F, Rendina EA, Longo F, De Giacomo T, Anile M, Mercadante E, Ventura L, Osti MF, Francioni F, Coloni GF (2003) Long-term outcome after multimodality treatment for stage III thymic tumors. Ann Thorac Surg 76: 1866–1872
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag/Wien
About this chapter
Cite this chapter
Lindner, M., Thetter, O., End, A. (2008). Andere thorakale Karzinome. In: Gnant, M., Schlag, P.M. (eds) Chirurgische Onkologie. Springer, Vienna. https://doi.org/10.1007/978-3-211-48613-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-211-48613-9_14
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-48612-2
Online ISBN: 978-3-211-48613-9
eBook Packages: Medicine (German Language)